United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

mckesson corporation dba rx pak - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide tablets are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

american health packaging - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide tablets are useful in the treatment of myasthenia gravis. pyridostigmine bromide tablets are contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

bausch health us, llc - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg in 5 ml - mestinon is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below.

United States - English - NLM (National Library of Medicine)

kaiser foundation hospitals - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 60 mg

United States - English - NLM (National Library of Medicine)

sandoz inc - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide 5 mg in 1 ml - regonol ® (pyridostigmine bromide injection, usp) is indicated as a reversal agent or antagonist to the neuromuscular blocking effects of nondepolarizing muscle relaxants. known hypersensitivity to anticholinesterase agents; intestinal and urinary obstructions of mechanical type.

Israel - English - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - tablets - pyridostigmine bromide 30 mg - pyridostigmine - pyridostigmine - pyridostigmine belongs to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.

Israel - English - Ministry of Health

rafa laboratories ltd - pyridostigmine bromide - tablets - pyridostigmine bromide 60 mg - pyridostigmine - pyridostigmine - pyridostigmine belons to the cholinesterase inhibitor group and is indicated for the treatment of myasthenia gravis.

United States - English - NLM (National Library of Medicine)

apnar pharma lp - pyridostigmine bromide (unii: kvi301na53) (pyridostigmine - unii:19qm69hh21) - pyridostigmine bromide oral solution is contraindicated in mechanical intestinal or urinary obstruction, and particular caution should be used in its administration to patients with bronchial asthma. care should be observed in the use of atropine for counteracting side effects, as discussed below. the safety of pyridostigmine bromide oral solution during pregnancy or lactation in humans has not been established. therefore, use of pyridostigmine bromide oral solution in women who may become pregnant requires weighing the drug's potential benefits against its possible hazards to mother and child. safety and effectiveness in pediatric patients have not been established.